Chester Freeman reflects on hiding the scars from his childhood tumor surgeries for decades and finally feeling comfortable in his own skin at 60.
|Articles|June 8, 2020
The Latest News and Updates in Chronic Lymphocytic Leukemia
Author(s)Jessica Skarzynski
Here is a roundup of the latest news and updates for patients with Chronic Lymphocytic Leukemia from CURE.
Advertisement
Known as the most common form of leukemia found in adults, chronic lymphocytic leukemia (CLL) has seen an influx of research in recent weeks. Here, CURE® takes a look back at some of the latest news and updates in the CLL space:
- A combination of cirmtuzumab plus Imbruvica (ibrutinib) could be beneficial in treating patients with mantle cell lymphoma (MCL) or CLL/small cell leukemia (SLL), according to new data from a phase 1b/2 study presented at the 2020 ASCO Virtual Scientific Program in late May.
- In other ASCO news, long term data has demonstrated that Calquence (acalabrutinib) is safe and effective in patients with treatment-naïve chronic lymphocytic leukemia, supporting its use in the front line setting in this population.
- Members of a family of targeted drugs used to treat blood cancer, known as BTK inhibitors, may be helpful in treating COVID-19, and some of these medications are being tested in clinical trials, experts explained in CURE®’s first-ever live webinar.
- Another study presented on at the Virtual Scientific Program has found that the combination of Venclexta (venetoclax) and Gazyva (obinutuzumab) elicited superior efficacy, compared to Leukeran (chlorambucil) and Gazyva in patients with previously untreated CLL.
- In CURE®’s webinar, “Hear from the Experts: COVID-19 & Cancer Care for Patients”, Dr. Ian Flinn and Dr. Saad Usmani addressed how the new coronavirus has affected stem cell transplants, as well as the management of CLL and myeloma clinical trials.
Advertisement
Related to this article
Diagnosed with leukemia at 8 years old, Harper feared that losing her hair would change who she was. She reflects on body image, confidence and finding a sense of herself during cancer treatment.
After 19 years of survivorship, one cancer survivor reflects on life's changing seasons, managing scan anxiety and finding support beyond treatment.
Psychiatrist Dr. Yesne Alici of Memorial Sloan Kettering Cancer Center answers questions about family relationships during cancer, from asking for help to talking with children and friends.
Among more than 12,000 cancer survivors 65 and older, those who stayed physically active after diagnosis tended to have lower health care costs, an American Cancer Society study published Oct. 21, 2026, in CANCER found.
The FDA grants traditional approval to Keytruda and Keytruda Qlex for TMB-H solid tumors, updating the threshold to at least 13 mutations per megabase.
Martha Carlson reflects on her 11 years with metastatic breast cancer and explores how resilience, purpose and the stories we tell ourselves shape the cancer experience.
A study found that 1 in 9 older cancer survivors developed a second cancer, highlighting why routine screening remains important beyond five years.
Advertisement
Advertisement
Trending on CURE
1
FDA Grants Traditional Approval to Keytruda for TMB-H Solid Tumors
2
FDA Clears AI Tool Using MRI to Gauge Breast Cancer Recurrence
3
Psychiatrist Answers Questions About Family and Relationships During Cancer
4
Why Cancer Screening Remains Important for Long-Term Cancer Survivors
5